Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L14 pseudogene 5 (RPL14P5) is a **processed pseudogene**—a genomic sequence similar to the functional RPL14 gene but typically nonfunctional and not translated into a biologically active protein[7]. Pseudogenes like RPL14P5 arise from formerly functional genes that have lost their protein-coding potential, often through mutations or truncations. Unlike the functional RPL14 gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis in the cytoplasm, RPL14P5 does not encode an active protein product nor a canonical molecular function[3][7]. Pseudogenes can occasionally be transcribed or even translated into short peptides, but there is no current evidence that RPL14P5 plays an established biological role, is targeted by drugs, or serves as a therapeutic target[5][7][8]. It is classified molecularly as a pseudogene and not as a gene-encoded protein, enzyme, transporter, or receptor. **Clarification:** - *Ribosomal protein L14* (abbreviated RPL14) is a real ribosomal protein involved in the ribosome's structure and function[1][3][4]. - *RPL14P5* is a processed pseudogene and not an active ribosomal protein, enzyme, or therapeutic target[7][8]. - There is nothing inherently incorrect about listing RPL14P5 as a pseudogene, but it is important to note that it is not considered a molecular target in pharmacology or drug discovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L14 pseudogene 5 (RPL14P5).